BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35733278)

  • 1. Lipopolysaccharide reduces melanin synthesis in vitiligo melanocytes by regulating autophagy.
    Sun L; Sun J; Huo X; Feng Q; Li Y; Xie X; Geng S
    Exp Dermatol; 2022 Oct; 31(10):1579-1585. PubMed ID: 35733278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toll-like receptor 4 activation inhibits melanogenesis in melanocytes].
    Sun L; Sun J; Huo X; Li Y; Li Y; Xie X; Hu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1466-1470. PubMed ID: 27774936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsaicin combined with stem cells improved mitochondrial dysfunction in PIG3V cells, an immortalized human vitiligo melanocyte cell line, by inhibiting the HSP70/TLR4/mTOR/FAK signaling axis.
    Wu Y; Wang X; Zhang J; Du S; Wang Z; Li J; Zhang W; Xiang J; Li R; Liu J; Bi X
    Mol Biol Rep; 2024 May; 51(1):650. PubMed ID: 38734811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocytes and melanin represent a first line of innate immunity against Candida albicans.
    Tapia CV; Falconer M; Tempio F; Falcón F; López M; Fuentes M; Alburquenque C; Amaro J; Bucarey SA; Di Nardo A
    Med Mycol; 2014 Jul; 52(5):445-54. PubMed ID: 24934806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo.
    Singh M; Mansuri MS; Kadam A; Palit SP; Dwivedi M; Laddha NC; Begum R
    Cytokine; 2021 Apr; 140():155432. PubMed ID: 33517195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of Toll-like receptor 7 and 9 in vitiligo melanocytes: a pilot study.
    Yu H; Lin X; Cen J; Cheng H; Seifert O
    Clin Exp Dermatol; 2021 Jan; 46(1):89-95. PubMed ID: 32945011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human melanocytes express functional Toll-like receptor 4.
    Ahn JH; Park TJ; Jin SH; Kang HY
    Exp Dermatol; 2008 May; 17(5):412-7. PubMed ID: 18400062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt/β-catenin signaling.
    Zou DP; Chen YM; Zhang LZ; Yuan XH; Zhang YJ; Inggawati A; Kieu Nguyet PT; Gao TW; Chen J
    Genes Dis; 2021 Sep; 8(5):677-688. PubMed ID: 34291139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT7 Inhibits Melanin Synthesis of PIG1 and PIG3V by Suppressing the Succinylation of EZR.
    Ma Y; Chang H
    Clin Cosmet Investig Dermatol; 2024; 17():1495-1504. PubMed ID: 38933605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple gene-drug prediction tool reveals Rosiglitazone based treatment pathway for non-segmental vitiligo.
    Zhao S; Chen X; Dutta K; Chen J; Wang J; Zhang Q; Jia H; Sun J; Lai Y
    Inflammation; 2024 Apr; 47(2):678-695. PubMed ID: 38159176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-17A receptor blocking in melanocyte survival: A strategic intervention against vitiligo.
    Bhardwaj S; Bhatia A; Kumaran MS; Parsad D
    Exp Dermatol; 2019 Jun; 28(6):682-689. PubMed ID: 30120811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
    Birlea SA; Costin GE; Norris DA
    Curr Drug Targets; 2008 Apr; 9(4):345-59. PubMed ID: 18393827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated ultraviolet irradiation induces the expression of Toll-like receptor 4, IL-6, and IL-10 in neonatal human melanocytes.
    Song HJ; Lee SH; Choi GS; Shin J
    Photodermatol Photoimmunol Photomed; 2018 Mar; 34(2):145-151. PubMed ID: 29063638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod induced vitiligo-like lesions-A consequence of modified melanocyte function.
    Yu H; Cen J; Lin X; Cheng H; Seifert O
    Immun Inflamm Dis; 2022 Jan; 10(1):70-77. PubMed ID: 34614305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of neuregulin1 in the lesional skin of vitiligo patients.
    Rani S; Kumari U; Bhardwaj S; Parsad D; Sharma VL; Kumar R
    Int J Dermatol; 2019 Feb; 58(2):242-249. PubMed ID: 30074619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanisms of hypopigmentation in lichen sclerosus.
    Carlson JA; Grabowski R; Mu XC; Del Rosario A; Malfetano J; Slominski A
    Am J Dermatopathol; 2002 Apr; 24(2):97-107. PubMed ID: 11979069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
    Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
    Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of inflammatory cytokines and chemokines in lipopolysaccharide-stimulated melanocytes from lightly and darkly pigmented skin.
    Tam I; Dzierżęga-Lęcznar A; Stępień K
    Exp Dermatol; 2019 May; 28(5):551-560. PubMed ID: 30801846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated autophagy increased melanocyte sensitivity to H
    He Y; Li S; Zhang W; Dai W; Cui T; Wang G; Gao T; Li C
    Sci Rep; 2017 Feb; 7():42394. PubMed ID: 28186139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impaired unfolded protein-premelanosome protein and transient receptor potential channels-autophagy axes in apoptotic melanocytes in vitiligo.
    Xie B; Song X
    Pigment Cell Melanoma Res; 2022 Jan; 35(1):6-17. PubMed ID: 34333860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.